login
login
Image header Agence Europe
Europe Daily Bulletin No. 12845
Contents Publication in full By article 22 / 38
EU RESPONSE TO COVID-19 / Health

New vaccine against Covid-19 to be evaluated by European Medicines Agency

On Thursday 2 December, the European Medicines Agency (EMA) announced that it had begun a rolling review of French pharmaceutical company Valneva’s vaccine candidate, VLA2001.

This is an inactivated vaccine and therefore contains a “killed” form of SARS-CoV-2 and two adjuvants that enhance the immune response to the vaccine.

When a person is given the vaccine, their immune system identifies the inactivated virus as foreign and makes antibodies against it. If, later, the vaccinated...

Contents

COURT OF JUSTICE OF THE EU
SECTORAL POLICIES
EXTERNAL ACTION
SECURITY - DEFENCE
EU RESPONSE TO COVID-19
ECONOMY - FINANCE - BUSINESS
INSTITUTIONAL
BREACHES OF EU LAW
NEWS BRIEFS